Challenges of vaccine development include regulatory, technical, and manufacturing hurdles in translating a vaccine candidate into a commercial product.
Suma Ray, PhD
Advertisement
Suma Ray, PhD, is a process development scientist, viral clearance and cell line development, Global Purification Technologies Group at Sartorius Stedim Biotech
Articles by Suma Ray, PhD
How to implement a risk-based approach to eliminate viruses using orthogonal technologies.
How to implement a risk-based approach to eliminating viruses.
Advertisement
Latest Updated Articles
Advertisement
Advertisement